DPP4 and diabetes mellitus: Our group previously conducted a small retrospective study of 26 patients with solid tumor diagnosis who were concomitantly taking DPP4 inhibitors for diabetes while on ICI treatment [43]: the objective response rate was 69% (18/26), although the results should be interpreted with caution due to the small sample size and lack of a comparison group.